Target intelligence / Profile preview

Glutamate receptor subunit AMPA type 1 (GluA1)

Target
GluA1
Molecular classification
Ion channel, Receptor, Ligand-gated ion channel, Ionotropic glutamate receptor
01

Overview

Glutamate receptor subunit AMPA type 1 (GluA1) is one of four core subunits (GluA1–GluA4) that assemble as homo- or hetero-tetrameric complexes to form the AMPA subtype of ionotropic glutamate receptors, which are ligand-gated cation channels mediating fast excitatory synaptic transmission in the central nervous system[1][2][4][5]. Upon glutamate binding, these receptors conduct Na⁺ and, depending on subunit composition, Ca²⁺ ions into the postsynaptic neuron, thereby initiating depolarization and synaptic signaling[1][2][4][5]. GluA1-containing AMPA receptors are particularly important for activity-dependent synaptic insertion during long-term potentiation (LTP), a cellular correlate of learning and memory, and are dynamically regulated via auxiliary proteins (e.g., TARPs, CNIH, GSG1L) that modulate trafficking, localization, and channel kinetics[1][2][3][4]. Dysregulation of GluA1 is implicated in several neurological and psychiatric conditions, and AMPARs are explored as drug targets for epilepsy, neurodegeneration, and other brain disorders[2][4][5].

Other names
AMPA receptor subunit GluA1α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor 1GRIA1GluR1 (older nomenclature)AMPAR subunit 1
02

Mechanism of action

Competitive antagonism (block glutamate binding), Non-competitive antagonism (stabilize closed/inactive channel state), Allosteric modulation (alter gating kinetics or channel conductance), Channel blocking (directly occlude the ion pore)

03

Biological functions

Fast excitatory neurotransmissionSynaptic plasticity (long-term potentiation and depression)Signal transductionMemory formationLearning
04

Disease associations

Neurodegenerative disease (e.g., Alzheimer’s disease)EpilepsySchizophreniaAutism spectrum disordersStroke/ischemiaOther psychiatric and neurological disorders
05

Safety considerations

Cognitive impairment (due to critical role in learning and memory)Risk of psychosis and behavioral effects (with antagonists)Excitotoxicity (overactivation can lead to neuronal damage/death)Seizures (overactivity or rapid upregulation implicated in epilepsy)Motor incoordination (due to disruption of fast excitatory signaling)
06

Interacting drugs

Perampanel (selective non-competitive antagonist)

4 more in the full profile.

07

Biomarkers

AMPA receptor subunit expression levels (in brain biopsies, CSF, or proxy imaging techniques can suggest excitotoxicity or synaptic dysfunction)Changes in synaptic GluA1 surface expression (for some neurological assays or in research settings)There are currently no widely established clinical biomarkers specific for GluA1-AMPAR in human patient selection; assessment is typically research-based.

Beyond the preview

Go deeper on Glutamate receptor subunit AMPA type 1 (GluA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor subunit AMPA type 1 (GluA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call